Insulin transdermal - Transdermal Global

Drug Profile

Insulin transdermal - Transdermal Global

Alternative Names: U-strip; U-Strip™ insulin patch; U-Strip™-insulin

Latest Information Update: 07 Jun 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dermisonics; Encapsulation Systems
  • Developer Transdermal Global
  • Class Antihyperglycaemics; Insulins; Pancreatic hormones
  • Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Phase I Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 24 Jul 2013 Biomarkers information updated
  • 31 May 2012 Phase-I development is ongoing with Transdermal Specialties for Diabetes mellitus in the USA
  • 31 May 2012 Transdermal Specialties plans a phase II trial for Diabetes mellitus (volunteers) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top